These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37578831)

  • 21. [Neuroprogression and cognition in Bipolar Disorders: A systematic review of cognitive performance in euthymic patients].
    Lolich M; Holtzman JN; Rago CM; Vázquez GH
    Vertex; 2015; 26(122):265-75. PubMed ID: 26672503
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive decline and neuroprogression in bipolar disorder: A case for Hitchens' razor.
    Szmulewicz A; Valerio M; Martino DJ
    Bipolar Disord; 2020 Aug; 22(5):536. PubMed ID: 32521083
    [No Abstract]   [Full Text] [Related]  

  • 23. Inflammatory Markers in the Staging of Bipolar Disorder: A Systematic Review of the Literature.
    Castaño-Ramírez OM; Sepúlveda-Arias JC; Duica K; Díaz Zuluaga AM; Vargas C; López-Jaramillo C
    Rev Colomb Psiquiatr (Engl Ed); 2018; 47(2):119-128. PubMed ID: 29754705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selfish brain and neuroprogression in bipolar disorder.
    Mansur RB; Cha DS; Asevedo E; McIntyre RS; Brietzke E
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():66-71. PubMed ID: 23266709
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cognitive aging of bipolar patients].
    Kohler S; Marlinge E
    Geriatr Psychol Neuropsychiatr Vieil; 2019 Jun; 17(2):179-188. PubMed ID: 31162118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Link between Refractoriness and Neuroprogression in Treatment-Resistant Bipolar Disorder.
    Bauer IE; Soares JC; Selek S; Meyer TD
    Mod Trends Pharmacopsychiatry; 2017; 31():10-26. PubMed ID: 28738324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first-episode mania and association with clinical outcome.
    Kozicky JM; McGirr A; Bond DJ; Gonzalez M; Silveira LE; Keramatian K; Torres IJ; Lam RW; Yatham LN
    Bipolar Disord; 2016 Sep; 18(6):511-519. PubMed ID: 27759214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The trajectory of neuropsychological dysfunctions in bipolar disorders: a critical examination of a hypothesis.
    Strejilevich SA; Samamé C; Martino DJ
    J Affect Disord; 2015 Apr; 175():396-402. PubMed ID: 25678172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bipolar disorder: staging and neuroprogression].
    Rodrigues AA; Rosa AR; Kunz M; Bruna A; Kapczinski F
    Psychiatr Pol; 2014; 48(2):231-43. PubMed ID: 25016762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year follow-up of cognitive impairment in older adults with bipolar disorder.
    Schouws SN; Comijs HC; Dols A; Beekman AT; Stek ML
    Bipolar Disord; 2016 Mar; 18(2):148-54. PubMed ID: 26961121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mediators of allostasis and systemic toxicity in bipolar disorder.
    Grande I; Magalhães PV; Kunz M; Vieta E; Kapczinski F
    Physiol Behav; 2012 Apr; 106(1):46-50. PubMed ID: 22079584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuron-glia Interaction as a Possible Pathophysiological Mechanism of Bipolar Disorder.
    Pinto JV; Passos IC; Librenza-Garcia D; Marcon G; Schneider MA; Conte JH; da Silva JPA; Lima LP; Quincozes-Santos A; Kauer-Sant Anna M; Kapczinski F
    Curr Neuropharmacol; 2018; 16(5):519-532. PubMed ID: 28847296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biological Pathways Associated with Neuroprogression in Bipolar Disorder.
    Wollenhaupt-Aguiar B; Kapczinski F; Pfaffenseller B
    Brain Sci; 2021 Feb; 11(2):. PubMed ID: 33673277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. From neuroprogression to neuroprotection: implications for clinical care.
    Berk M; Conus P; Kapczinski F; Andreazza AC; Yücel M; Wood SJ; Pantelis C; Malhi GS; Dodd S; Bechdolf A; Amminger GP; Hickie IB; McGorry PD
    Med J Aust; 2010 Aug; 193(S4):S36-40. PubMed ID: 20712560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virginia Woolf, neuroprogression, and bipolar disorder.
    Boeira MV; Berni GÁ; Passos IC; Kauer-Sant'Anna M; Kapczinski F
    Braz J Psychiatry; 2017; 39(1):69-71. PubMed ID: 27304258
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling mania in preclinical settings: A comprehensive review.
    Sharma AN; Fries GR; Galvez JF; Valvassori SS; Soares JC; Carvalho AF; Quevedo J
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Apr; 66():22-34. PubMed ID: 26545487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The staging model (or evolutionary stages) applied to bipolar disorder].
    Scott J; Henry C
    Encephale; 2018 Dec; 44(6S):S30-S33. PubMed ID: 30935484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biomarkers and staging of bipolar disorder: a systematic review.
    Roda Â; Chendo I; Kunz M
    Trends Psychiatry Psychother; 2015; 37(1):3-11. PubMed ID: 25860561
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research.
    Rizzo LB; Costa LG; Mansur RB; Swardfager W; Belangero SI; Grassi-Oliveira R; McIntyre RS; Bauer ME; Brietzke E
    Neurosci Biobehav Rev; 2014 May; 42():157-69. PubMed ID: 24548785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stage managing bipolar disorder.
    Berk M; Berk L; Dodd S; Cotton S; Macneil C; Daglas R; Conus P; Bechdolf A; Moylan S; Malhi GS
    Bipolar Disord; 2014 Aug; 16(5):471-7. PubMed ID: 23782499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.